Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 31 crawled time : 13:20 save search
Context Therapeutics’ Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU™ (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
CNTX | $1.38 -2.13% -2.17% 37K
|
Health Technology
|
| O: 78.62%
H: 27.05%
C: -13.11%
fda breast approval cancer group elascestrant orserdu ona-xr her2- her2
Halberd to Conduct Animal Tests of Nasal Spray that Blocks Negative Effects of Head Trauma
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
HALB | $0.0082 7.14% 540K
|
n/a
|
| O: 15.38%
H: 0.0%
C: -5.56%
spray animal negative
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 0.68%
H: 0.0%
C: 0.0%
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -0.21%
H: 8.3%
C: 6.49%
pedmark fda pharmaceuticals drug
BPA Solutions Confirms Initial Order of Units to a University in North Carolina To Improve Indoor Air Quality
Published: 2023-01-31 (Crawled : 13:20) - singlepoint.com
SING | $0.1859 -8.42% 0.81% 510K
|
|
| O: -1.67%
H: 9.83%
C: 6.95%
air solutions order
Karuna Therapeutics Appoints William P. Kane as Chief Commercial Officer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.74%
H: 3.19%
C: 1.5%
commercial therapeutics
Emergent Health Appoints Former Kraft Foods Director of National Accounts Charlie McMenamin to Its Board of Directors
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
EMGE | $0.0024 94.44% 470K
|
Wholesale Trade
|
| O: 2.13%
H: 8.33%
C: -2.08%
foods health
Casma Therapeutics Announces CEO Transition
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
CRIS | $14.705 -2.03% -2.07% 4.7K
|
Health Technology
|
| O: 0.64%
H: 2.2%
C: -5.04%
ceo therapeutics
Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
ATHA | $2.02 -0.98% -0.99% 78K
|
Health Technology
|
| O: 0.26%
H: 5.13%
C: 3.59%
pharma
Optinose Announces CEO Transition and Business Update
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
OPTN | $0.92 -4.93% -5.18% 570K
|
Health Services
|
| O: 0.57%
H: 6.29%
C: 2.29%
ceo update
KemPharm Enhances Senior Management Team
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
management
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
AEMD 4 | $1.5119 1.33% 620
|
Health Technology
|
| O: -9.18%
H: 8.81%
C: 1.79%
conference medical
Rakuten Advertising named mThink's Best Affiliate Network for 12 Consecutive Years
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
RKUNF | $4.908 -22.65% 1K
|
Consumer Services
|
| O: -2.53%
H: 2.2%
C: 2.2%
RKUNY | $4.95 1.45% 13K
|
Retail Trade
|
| O: 1.18%
H: 0.0%
C: -2.13%
network
Reviva Pharmaceuticals to Present at the 2023 BIO CEO and Investor Conference
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
RVPH | $3.02 -1.31% -1.32% 78K
|
|
| O: 1.15%
H: 13.47%
C: 8.68%
pharmaceuticals ceo conference
Aptinyx to Present at the SVB Securities Global Biopharma Conference
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
| Email alert
Add to watchlist
biopharma global conference
CADIZ INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING BACKED BY LARGEST SHAREHOLDERS
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
CDZI P | $2.28 1.79% 1.75% 200K
|
Utilities
|
| O: 1.04%
H: 3.61%
C: 3.09%
offering direct
“Nothing defensive” about Marsh McLennan restructuring – CEO – Insurance Business
Published: 2023-01-31 (Crawled : 13:20) - spacfeed.com
BACA | $10.38 0.0% 3
|
n/a
|
| O: 0.0%
H: 0.0%
C: 0.0%
EXPR | $0.83 -9.64% 440K
|
Retail Trade
|
| O: 0.0%
H: 3.48%
C: 0.87%
ceo insurance
9 Meters Biopharma to Present at the 2023 BIO CEO & Investor Conference
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 0.5%
H: 4.5%
C: 1.0%
biopharma ceo conference
Chunghwa Telecom Reports 2023 Guidance
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
CHT | $38.24 -0.91% 0.0% 100K
|
Communications
|
| O: -1.18%
H: 0.0%
C: -1.88%
CureVac von LexisNexis® als einer der weltweit dynamischsten Innovatoren ausgezeichnet
Published: 2023-01-31 (Crawled : 13:20) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -1.73%
H: 3.25%
C: -5.62%
lexisnexis als
Amneal to Report Fourth Quarter and Full Year 2022 Results on March 2, 2023
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: 0.96%
H: 4.27%
C: 4.27%
report year results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.